Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Amorçage Rhône Alpes

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$6M
Portfolio companies 3
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 2
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Biopharma
  • Medical
  • Software
  • Computer
Summary

Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Medical, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Nanobiotix, Oslo Software, ERYtech Pharma.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Amoru00e7age Rhu00f4ne Alpes, startups are often financed by CapDecisif. The meaningful sponsors for the fund in investment in the same round are CapDecisif, Seventure Partners, Rhone-Alpes Creation. In the next rounds fund is usually obtained by Auriga Partners, European Investment Bank (EIB), Script Capital.

The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2017. This Amoru00e7age Rhu00f4ne Alpes works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2006.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Amorçage Rhône Alpes:
Typical Co-investors
Amorçage Rhône Alpes is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Amorçage Rhône Alpes:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
A-Labs Advisory & Finance HaMerkaz, Israel, Kadima
Ancora Cleveland, Ohio, United States
Aozora Bank Ltd. New York, New York, United States
Capital for Enterprise England, Sheffield, United Kingdom
Handmade Ventures California, San Mateo, United States
Innovation In Motion -
Jetty Ventures Central, Central Region, Singapore
Lakeside Invest & Consult Kreuzlingen, Switzerland, Thurgau
Mainspring Capital Arizona, Scottsdale, United States
Ningbo Xuri Lamp Decoration China, Xiangshan, Zhejiang
Northern Powerhouse Investment Fund England, Sheffield, United Kingdom
Overline VC Atlanta, Georgia, United States
RAJ Capital California, Newport Beach, United States
Roche Venture Fund Basel, Basel-Stadt, Switzerland
Salvia GmbH Bayern, Germany, Holzkirchen
Spectrum Assets Connecticut, Stamford, United States
TPY Capital Israel, Tel Aviv, Tel Aviv
Westlake International Group California, San Mateo, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Nanobiotix

Biotechnology
Health Care
Therapeutics
$8M05 May 2010 Paris, Ile-de-France, France

Computer
Software
$1M31 Aug 2006 France, Auvergne-Rhône-Alpes

erytech

Biopharma
Biotechnology
Medical
$885K03 Nov 2005 France, Auvergne-Rhône-Alpes

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Amorçage Rhône Alpes?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 6M
Peak activity year 2006
Lead investments 0
Follow on index 0.25
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Nanobiotix

Biotechnology
Health Care
Therapeutics
$8M05 May 2010 Paris, Ile-de-France, France

Computer
Software
$1M31 Aug 2006 France, Auvergne-Rhône-Alpes

erytech

Biopharma
Biotechnology
Medical
$885K03 Nov 2005 France, Auvergne-Rhône-Alpes
Crunchbase icon

Content report

The following text will be sent to our editors: